# FDA Inspection 1253065 - Biomat USA, Inc. - October 24, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/8a42d289-0456-47cc-9d26-15c2d1816cf6
Source feed: FDA_Inspections

> FDA Inspection 1253065 for Biomat USA, Inc. on October 24, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1253065
- Company Name: Biomat USA, Inc.
- Inspection Date: 2024-10-24
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1253065 - 2024-10-24](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/8367027f-f77b-4131-b44e-3aba3c2678eb)
- [FDA Inspection 1086184 - 2019-03-21](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/ea5902f9-4f7c-470e-9ace-345edcf064ae)
- [FDA Inspection 950823 - 2015-10-23](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/be4aa30a-4a30-4d46-ab1d-ac53ad6daf25)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/6867a850-59f9-4ee1-a3c0-55961ba7ea6d

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d